Augmentin IV Dosage for Adults with Bacterial Infections
For adults with bacterial infections, the recommended IV dosage of Augmentin (amoxicillin/clavulanate) is 1.2 g (1000 mg amoxicillin/200 mg clavulanate) every 6-8 hours for most infections, with more severe infections requiring doses up to 1.2 g every 4-6 hours. 1
Dosing Guidelines Based on Infection Type
Standard Dosing
- For most bacterial infections in adults, Augmentin IV should be administered at 1.2 g every 6-8 hours 1
- For more severe infections, particularly respiratory tract infections, the dose should be increased to 1.2 g every 4-6 hours 1
Specific Infection Types
Skin and Soft Tissue Infections (SSTI):
Respiratory Tract Infections:
Intra-abdominal Infections:
- 1.2 g IV every 6-8 hours, with duration based on clinical response 1
Special Population Considerations
Renal Impairment
- For patients with creatinine clearance 10-30 mL/min: 1.2 g IV initially, then 600 mg IV every 12 hours 1
- For patients with creatinine clearance <10 mL/min: 1.2 g IV initially, then 600 mg IV every 24 hours 1
- Hemodialysis patients should receive an additional dose during and at the end of dialysis 1
Hepatic Impairment
- No specific dose adjustment is required for hepatic impairment alone 1
- Monitor liver function tests in patients with evidence of hepatic dysfunction 1
Duration of Therapy
- Uncomplicated infections: 7-10 days 2
- Complicated infections: 14-21 days, depending on clinical response 2
- Bacteremia or endocarditis:
Administration Guidelines
- Administer by slow intravenous injection over 3-4 minutes or by intravenous infusion over 30-40 minutes 1
- For infusion, dilute in appropriate IV solution (typically 0.9% sodium chloride or 5% dextrose) 1
- Reconstituted solution should be used within 4 hours if stored at room temperature 1
Common Pitfalls and Caveats
- Do not confuse IV and oral dosing: IV Augmentin has different dosing than oral formulations 1
- Monitor for hypersensitivity reactions: Patients with a history of penicillin allergy may experience cross-reactivity 1
- Assess renal function: Dosage adjustment is necessary in patients with renal impairment 1
- Superinfection risk: Prolonged use may result in overgrowth of non-susceptible organisms 1
- C. difficile-associated diarrhea: Monitor for diarrhea during and after treatment 2
- Transition to oral therapy: Consider switching to oral Augmentin when clinically appropriate to reduce IV-related complications 3
Augmentin IV remains a valuable broad-spectrum antibiotic for treating various bacterial infections, particularly when oral therapy is not appropriate or when treating more severe infections requiring higher tissue concentrations of the antibiotic.